Literature DB >> 22180433

Exome sequencing identifies MPL as a causative gene in familial aplastic anemia.

Amanda J Walne1, Arran Dokal, Vincent Plagnol, Richard Beswick, Michael Kirwan, Josu de la Fuente, Tom Vulliamy, Inderjeet Dokal.   

Abstract

The primary cause of aplastic anemia remains unknown in many patients. The aim of this study was to clarify the genetic cause of familial aplastic anemia. Genomic DNA of an affected individual from a multiplex consanguineous family was hybridized to a Nimblegen exome library before being sequenced on a GAIIx genome analyzer. Once the disease causing homozygous mutation had been confirmed in the consanguineous family, this gene was then analyzed for mutation in 33 uncharacterized index cases of aplastic anemia (<13 years) using denaturing HPLC. Abnormal traces were confirmed by direct sequencing. Exome sequencing identified a novel homozygous nonsense mutation in the thrombopoietin receptor gene MPL. An additional novel homozygous MPL mutation was identified in the screen of 33 aplastic anemia patients. This study shows for the first time a link between homozygous MPL mutations and familial aplastic anemia. It also highlights the important role of MPL in trilineage hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180433      PMCID: PMC3347658          DOI: 10.3324/haematol.2011.052787

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  20 in total

1.  Inherited bone marrow failure syndromes.

Authors:  Inderjeet Dokal; Tom Vulliamy
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

Review 2.  Molecular mechanisms of thrombopoietin signaling.

Authors:  K Kaushansky
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 3.  Next-generation DNA sequencing methods.

Authors:  Elaine R Mardis
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

4.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Authors:  S W Knight; T J Vulliamy; N S Heiss; G Matthijs; K Devriendt; J M Connor; M D'Urso; A Poustka; P J Mason; I Dokal
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

Review 5.  Novel genomic techniques open new avenues in the analysis of monogenic disorders.

Authors:  Gregor Kuhlenbäumer; Julia Hullmann; Silke Appenzeller
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

Review 6.  The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis.

Authors:  Fu-Sheng Chou; James C Mulloy
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

7.  Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia.

Authors:  K Ihara; E Ishii; M Eguchi; H Takada; A Suminoe; R A Good; T Hara
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

9.  MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.

Authors:  Manuela Germeshausen; Matthias Ballmaier; Karl Welte
Journal:  Hum Mutat       Date:  2006-03       Impact factor: 4.878

10.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more
  17 in total

Review 1.  Applications of high-throughput DNA sequencing to benign hematology.

Authors:  Vijay G Sankaran; Patrick G Gallagher
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

Review 2.  Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

Authors:  Daria V Babushok; Monica Bessler
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

3.  Genetic characterization of acquired aplastic anemia by targeted sequencing.

Authors:  Michael Heuser; Carola Schlarmann; Vera Dobbernack; Victoria Panagiota; Lutz Wiehlmann; Carolin Walter; Fabian Beier; Patrick Ziegler; Haiyang Yun; Sofia Kade; Aylin Kirchner; Liu Huang; Christian Koenecke; Matthias Eder; Tim H Brümmendorf; Martin Dugas; Arnold Ganser; Felicitas Thol
Journal:  Haematologica       Date:  2014-06-06       Impact factor: 9.941

Review 4.  Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.

Authors:  Andrea Bacigalupo; Sabrina Giammarco; Simona Sica
Journal:  Int J Hematol       Date:  2016-06-08       Impact factor: 2.490

Review 5.  Exome sequencing greatly expedites the progressive research of Mendelian diseases.

Authors:  Xuejun Zhang
Journal:  Front Med       Date:  2014-01-03       Impact factor: 4.592

Review 6.  Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

7.  Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin.

Authors:  Aaron Seo; Miri Ben-Harosh; Mehtap Sirin; Jerry Stein; Orly Dgany; Joseph Kaplelushnik; Manfred Hoenig; Ulrich Pannicke; Myriam Lorenz; Klaus Schwarz; Clemens Stockklausner; Tom Walsh; Suleyman Gulsuner; Ming K Lee; Anoop Sendamarai; Marilyn Sanchez-Bonilla; Mary-Claire King; Holger Cario; Andreas E Kulozik; Klaus-Michael Debatin; Ansgar Schulz; Hannah Tamary; Akiko Shimamura
Journal:  Blood       Date:  2017-05-30       Impact factor: 22.113

Review 8.  Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.

Authors:  Danielle M Townsley; Ronan Desmond; Cynthia E Dunbar; Neal S Young
Journal:  Int J Hematol       Date:  2013-05-21       Impact factor: 2.490

9.  Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.

Authors:  Majed J Dasouki; Syed K Rafi; Adam J Olm-Shipman; Nathan R Wilson; Sunil Abhyankar; Brigitte Ganter; L Mike Furness; Jianwen Fang; Rodrigo T Calado; Irfan Saadi
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113

Review 10.  Genomic characterization of the inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.